REBUILDING CONFIDENCE IN VACCINES: A NEW APPROACH

March 21, 2019

Vaccines are among the best tools we have to protect people’s health. And yet, public confidence in vaccines is under threat as never before. So what can we do to stop this dangerous trend and rebuild public trust? A new global policy approach is needed, one that takes public concerns seriously, builds more time for dialogue and patient consultation into increasingly stressed health services, supports public health officials and professionals to build their own confidence and have the answers they need when confronted with questions and concerns. At the same time, we must not shy away from confronting those who undermine the facts behind vaccine safety, real risks and benefits. Otherwise, there is a serious risk that global immunization goals could be undermined and public health compromised.

Spotlight

DRG Abacus

DRG Abacus, a Decision Resources Group company formally known as Abacus International, specialises in health outcomes; economic modelling, HTA, medical writing and market access services. Our client base includes the global and local affiliates of many of the leading pharmaceutical and devic.

Other Infographics
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More

Spotlight

DRG Abacus

DRG Abacus, a Decision Resources Group company formally known as Abacus International, specialises in health outcomes; economic modelling, HTA, medical writing and market access services. Our client base includes the global and local affiliates of many of the leading pharmaceutical and devic.

Events